Co-Production With Families, Carers and Support Networks in Mental Health Services
Families and carers are central to long-term mental health support, yet their involvement is frequently informal and inconsistently governed. In this series on mental health co-production and lived experience, we emphasise structured, accountable involvement. This must also align with wider mental health service models and pathways, because risk, escalation and recovery rarely sit with the individual alone. This article explores how providers co-produce safely with families and support networks while balancing confidentiality, safeguarding and positive risk-taking.
Clarifying roles and boundaries
Family involvement requires clarity about consent, information sharing and decision-making authority. Co-production with families does not override the autonomy of the individual, nor does it transfer clinical responsibility. Instead, it ensures that where consent is given, families understand early warning signs, crisis plans and escalation routes.
Operational Example 1: Co-producing crisis and relapse plans with families
Context: A provider identified repeated crisis presentations where families reported noticing deterioration earlier but were unsure how to escalate concerns.
Support approach: Care coordinators facilitated structured planning meetings involving the individual, family (with consent), and clinical lead. Safeguarding oversight ensured confidentiality boundaries were respected.
Day-to-day delivery detail: Plans included:
- Early warning signs agreed by all parties.
- Clear contact points and timeframes.
- Escalation thresholds and out-of-hours arrangements.
Evidence of effectiveness: Crisis admissions linked to unrecognised deterioration reduced. Audit sampling showed improved documentation of shared warning signs and escalation pathways.
Operational Example 2: Carer-informed review of engagement processes
Context: Disengagement from services was often preceded by missed appointments and reduced communication. Families reported uncertainty about whether to intervene.
Support approach: A co-produced review session examined how the service responded to missed contact. Carer representatives highlighted gaps in follow-up clarity.
Day-to-day delivery detail: The provider implemented a structured follow-up protocol for higher-risk individuals: same-day attempt, documented outcome, and consent-based notification to carers where appropriate. MDT meetings included a standing item reviewing “loss of contact” cases.
Evidence of effectiveness: DNA follow-up compliance improved and safeguarding alerts related to loss of contact reduced over two reporting cycles.
Operational Example 3: Supporting families in medication and physical health monitoring
Context: Families often observed medication side effects or physical health decline before professionals, but felt excluded from discussions.
Support approach: With consent, medication reviews included structured opportunities for family input. Clinical leads retained responsibility for prescribing decisions and risk management.
Day-to-day delivery detail: Reviews included documented discussion of side effects, adherence concerns and physical health checks. Families were given clear guidance on when to raise urgent concerns and how to access advice outside routine appointments.
Evidence of effectiveness: Improved adherence rates and earlier identification of side effects were recorded. Audit sampling showed clearer documentation of shared discussions and escalation advice.
Commissioner Expectation: Evidence of meaningful family involvement
Commissioner expectation: Commissioners expect providers to evidence how families are involved (with consent) in safety planning, discharge and engagement processes, particularly where risk of relapse or safeguarding concerns are present.
Regulator / Inspector Expectation: Balancing confidentiality and safeguarding
Regulator / Inspector expectation: Inspectors assess whether services balance confidentiality with the duty to prevent harm. They expect clear documentation of consent, boundaries, escalation decisions and positive risk-taking rationale.
Embedding family co-production into governance
Providers sustain safe family involvement through written protocols, consent documentation, supervision review, MDT oversight and audit of relapse and escalation patterns. When structured properly, family co-production strengthens safety, continuity and recovery without diluting professional accountability.